Toronto, Ontario--(Newsfile Corp. - Le 24 novembre/November 2025) - Trading in the shares of Psyence Group Inc. (PSYG) will remain halted pending receipt and review of acceptable documentation regarding the Fundamental Change pursuant to CSE Policy 8. This regulatory halt is imposed by Canadian Investment Regulatory Organization, the Market Regulator of the Exchange, pursuant to the provisions of Section 10.9(1) of the Universal Market Integrity Rules. Please see the issuer's news release for further det ...

Core Insights - TAG Oil Ltd. has engaged ICP Securities Inc. for automated market making services, utilizing its proprietary algorithm, ICP Premium™, to enhance liquidity and comply with TSX Venture Exchange regulations [1][2] - The agreement with ICP is for an initial term of four months, with a monthly fee of C$7,500, and will automatically renew unless terminated with a 30-day notice [1] - ICP Securities Inc. is a Toronto-based dealer specializing in automated market making and liquidity provision, established in 2023 [2] - TAG Oil is an international oil and gas exploration company focused on the Middle East and North Africa [3]

Core Points - Decade Resources Ltd. has successfully closed a private placement, raising total gross proceeds of $1,170,000 [1] - The private placement consisted of two types of units: flow-through units and non-flow-through units [2][3] Flow-Through Units - A total of 24,250,000 flow-through units were issued at a price of 4 cents per unit, generating gross proceeds of $970,000 [2] - Each flow-through unit includes one common share and one warrant, with the warrant exercisable at $0.06 per share for a period of 24 months [2] - Proceeds from flow-through units will be allocated to Canadian exploration expenses and critical mineral mining expenditures on the company's B.C. properties [4] Non-Flow-Through Units - A total of 5,000,000 non-flow-through units were issued at a price of 4 cents per unit, generating gross proceeds of $200,000 [3] - Each non-flow-through unit consists of one common share and one warrant, with the warrant exercisable at $0.06 per share for a period of 36 months [3] - Proceeds from non-flow-through units will be used for general working capital [4] Additional Information - The company paid cash finder's fees totaling $86,800 and issued 2,170,000 warrants to finders, which are exercisable for a 24-month period [5] - All securities issued are subject to a statutory hold period of four months, expiring on March 22, 2026 [5]

Core Viewpoint - Rosen Law Firm is urging investors of Cepton, Inc. to secure legal counsel before the December 8, 2025 deadline related to a securities class action lawsuit concerning misleading statements made by the company during the class period from July 29, 2024, to January 6, 2025 [1][5]. Group 1: Legal Action Details - Investors who purchased or sold Cepton common stock during the specified class period may be eligible for compensation without incurring out-of-pocket fees through a contingency fee arrangement [2]. - To participate in the class action, investors must act before the December 8, 2025 deadline to serve as lead plaintiff, which involves directing the litigation on behalf of other class members [3][6]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting its own success in achieving significant settlements for investors, including over $438 million in 2019 [4]. - The firm has been recognized for its leadership in securities class action settlements, being ranked No. 1 in 2017 and consistently in the top 4 since 2013 [4]. Group 3: Allegations Against Cepton, Inc. - The lawsuit alleges that Cepton's management made materially false and misleading statements regarding the company's business and operations, including failing to disclose a credible third-party bid that valued Cepton at more than double the Koito Acquisition [5]. - It is claimed that the Board of Directors did not adequately explore this offer or disclose its terms, depriving shareholders of the opportunity to make an informed decision regarding the Koito Acquisition [5].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased common stock of Inspire Medical Systems, Inc. during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [2][4]. Group 1: Class Action Details - Investors who bought Inspire Medical common stock between August 6, 2024, and August 4, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by January 5, 2026 [4][6]. - The lawsuit alleges that Inspire Medical misrepresented key facts about its sleep apnea device, Inspire V, including market demand and necessary steps for its launch, leading to investor damages when the truth was revealed [6]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in this area [5]. - The firm has secured significant settlements for investors, including over $438 million in 2019, and has been consistently ranked among the top firms for securities class action settlements since 2013 [5].

Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of Skye Bioscience, Inc. securities during the specified Class Period, indicating potential legal issues surrounding the company's disclosures and business practices [1][5]. Group 1: Class Action Details - The class action lawsuit pertains to securities purchased between November 4, 2024, and October 3, 2025, and aims to address alleged misleading statements made by the company regarding its product, nimacimab [1][5]. - Investors who purchased Skye securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. Group 2: Allegations Against Skye Bioscience - The lawsuit claims that Skye Bioscience made materially false and misleading statements about its business operations and the effectiveness of nimacimab, which were overstated [5]. - Specific allegations include that nimacimab was less effective than claimed, and that the company's clinical, regulatory, and commercial prospects were misrepresented [5]. Group 3: Legal Representation - Investors interested in joining the class action can do so by contacting Rosen Law Firm through their website or phone [3][6]. - It is noted that no class has been certified yet, and investors are advised they may select their own counsel or remain absent from the class [7]. Group 4: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements in the past, including the largest securities class action settlement against a Chinese company [4]. - The firm has consistently ranked highly in terms of securities class action settlements and has recovered hundreds of millions of dollars for investors [4].

Group 1 - The Beachbody Company, Inc. (BODi) will participate in a Fireside Chat at NobleCon21 on December 3rd, featuring key executives including Mark Goldston, Carl Daikeler, and Brad Ramberg [1] - A high-definition video webcast of the presentation will be available on the company's website and Noble Capital Markets' conference website, archived for 90 days [2] - BODi has been innovating home fitness and nutrition programs for 26 years, helping over 30 million customers achieve life-changing results [4] Group 2 - Noble Capital Markets, established in 1984, is a full-service broker-dealer providing investment and advisory services, with a focus on middle-market expertise [6] - NobleCon is a large-scale in-person conference hosted by Noble, along with multi-sector virtual conferences throughout the year [6] - Channelchek, launched in 2018, offers free institutional-quality research on emerging growth public companies, featuring over 7,000 companies [7]

Core Viewpoint - Elauwit Connection, Inc. has successfully closed the sale of an additional 68,989 shares as part of the underwriter's partial exercise of its over-allotment option in connection with its initial public offering, raising an additional $0.6 million on top of the previously announced $15.0 million from the IPO [1]. Group 1: Offering Details - The offering was conducted on a firm commitment basis, with Craig-Hallum Capital Group LLC serving as the sole bookrunner [2]. - The registration statement for the offering was filed with the U.S. Securities and Exchange Commission and became effective on November 2, 2025 [3]. Group 2: Company Overview - Elauwit is a national managed services provider that specializes in designing, building, and operating premium broadband and property-wide WiFi networks for multifamily and student housing communities [5]. - The company focuses on service quality, reliability, and measurable asset value, enabling property owners to provide always-on connectivity as a modern amenity and a source of recurring net operating income growth [5].

Core Insights - P3 Health Partners Inc. will participate in the Noble Capital Markets' 21st Annual Emerging Growth Equity Conference on December 3, 2025 [1][2] - The company focuses on population health management, aiming to improve healthcare outcomes for patients and providers [3] Company Overview - P3 Health Partners is a physician-led organization with a network of over 2,800 affiliated primary care providers across the United States [3] - The company operates in 27 counties across five states, managing care for thousands of patients [3] - P3 supports primary care providers through value-based care coordination and administrative services, which enhance patient outcomes and reduce costs [3] - The organization emphasizes an integrated approach to patient care, improving the overall patient experience [3]

Core Viewpoint - Pasofino Gold Limited is experiencing renewed momentum due to an updated feasibility study and a recent financing of C$12 million for its 100%-owned Dugbe Gold Project in Liberia, which contains 3.9 million ounces of gold and benefits from strong local support [1]. Company Overview - Pasofino Gold Limited is a Canadian-based mineral exploration company listed on the TSX Venture Exchange, owning 100% of the Dugbe Gold Project, subject to a 10% carried interest from the Government of Liberia [2]. Project Details - The Dugbe Gold Project is located in Liberia and is highlighted for its significant gold reserves of 3.9 million ounces, positioning it as a key asset amid a global gold bull run [1]. - The company emphasizes Liberia's stability as one of Africa's most favorable jurisdictions for mining investments [1].